DK1849762T3 - Substituerede biphenylcarboxylsyrer og derivater deraf - Google Patents

Substituerede biphenylcarboxylsyrer og derivater deraf

Info

Publication number
DK1849762T3
DK1849762T3 DK06112938T DK06112938T DK1849762T3 DK 1849762 T3 DK1849762 T3 DK 1849762T3 DK 06112938 T DK06112938 T DK 06112938T DK 06112938 T DK06112938 T DK 06112938T DK 1849762 T3 DK1849762 T3 DK 1849762T3
Authority
DK
Denmark
Prior art keywords
derivatives
biphenylcarboxylic acids
substituted biphenylcarboxylic
substituted
acids
Prior art date
Application number
DK06112938T
Other languages
Danish (da)
English (en)
Inventor
Francis Wilson
Alison Reid
Valerie Reader
Richard John Harrison
Mihiro Sunose
Remedios Hernandez-Perni
Jeremy Major
Cyrille Boussard
Kathryn Smelt
Jess Taylor
Adeline Leformal
Andrew Cansfield
Svenja Burckhardt
Original Assignee
Cellzome Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellzome Ltd filed Critical Cellzome Ltd
Application granted granted Critical
Publication of DK1849762T3 publication Critical patent/DK1849762T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK06112938T 2006-04-21 2006-04-21 Substituerede biphenylcarboxylsyrer og derivater deraf DK1849762T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112938A EP1849762B1 (fr) 2006-04-21 2006-04-21 Acides biphényl carboxyliques substitués et leurs dérivés

Publications (1)

Publication Number Publication Date
DK1849762T3 true DK1849762T3 (da) 2009-10-12

Family

ID=36688012

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06112938T DK1849762T3 (da) 2006-04-21 2006-04-21 Substituerede biphenylcarboxylsyrer og derivater deraf

Country Status (35)

Country Link
US (1) US7557244B2 (fr)
EP (2) EP1849762B1 (fr)
JP (1) JP5479088B2 (fr)
KR (1) KR101542255B1 (fr)
CN (1) CN101687758B (fr)
AP (1) AP2008004656A0 (fr)
AR (1) AR060568A1 (fr)
AU (1) AU2007240335B2 (fr)
BR (1) BRPI0710656A2 (fr)
CA (1) CA2650006C (fr)
CR (2) CR10375A (fr)
CY (1) CY1109399T1 (fr)
DE (1) DE602006007810D1 (fr)
DK (1) DK1849762T3 (fr)
EA (1) EA016129B9 (fr)
ES (2) ES2328616T3 (fr)
GE (1) GEP20115269B (fr)
GT (1) GT200900120A (fr)
IL (2) IL194852A0 (fr)
MA (1) MA30475B1 (fr)
MX (1) MX2008013445A (fr)
MY (1) MY148953A (fr)
NO (1) NO20084517L (fr)
NZ (1) NZ573000A (fr)
PE (1) PE20080364A1 (fr)
PL (1) PL1849762T3 (fr)
PT (1) PT1849762E (fr)
SI (1) SI1849762T1 (fr)
SM (1) SMP200800061B (fr)
TN (1) TNSN08413A1 (fr)
TW (1) TWI399362B (fr)
UA (1) UA95952C2 (fr)
UY (1) UY30301A1 (fr)
WO (1) WO2007124394A1 (fr)
ZA (1) ZA200809856B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0817433A2 (pt) 2007-10-19 2015-06-16 Janssen Pharmaceutica Nv Moduladores de gama-secretase piperidinila e piperazinila
AU2008312355B2 (en) 2007-10-19 2013-07-04 Janssen Pharmaceutica, N.V. Carbon linked modulators of y-secretase
EA018862B1 (ru) 2007-10-19 2013-11-29 Янссен Фармацевтика, Н.В. МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ
CN101903334A (zh) * 2007-10-19 2010-12-01 詹森药业有限公司 Gsm中间体
WO2009067493A2 (fr) * 2007-11-19 2009-05-28 Envivo Pharmaceuticals, Inc. Benzènes 1,3,5-trisubstitués pour le traitement de la maladie d'alzheimer et d'autres troubles
RU2527177C2 (ru) 2007-12-20 2014-08-27 Энвиво Фармасьютикалз, Инк. Четырехзамещенные бензолы
WO2011046774A1 (fr) * 2009-10-16 2011-04-21 Merck Sharp & Dohme Corp. Dérivés d'éther diarylique comme inhibiteurs de la gamma-sécrétase n'agissant pas sur la voie notch
US8785481B2 (en) 2010-09-29 2014-07-22 Merck Sharp & Dohme Corp. Ether benzotriazole derivatives
CA2828764A1 (fr) * 2011-03-03 2012-09-07 Treventis Corporation Composes anti-amyloides et procedes
WO2015109109A1 (fr) 2014-01-15 2015-07-23 Forum Pharmaceuticals Inc. Morpholino-pyrimidines fusionnées et leurs procédés d'utilisation
WO2016201168A1 (fr) 2015-06-10 2016-12-15 Forum Pharmceuticals Inc. Composés oxadiazine et leurs méthodes d'utilisation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877399A (en) 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
JP3802581B2 (ja) * 1995-03-01 2006-07-26 富山化学工業株式会社 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤
AU5702201A (en) 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
DE10131899A1 (de) 2001-07-04 2003-02-27 Boehringer Ingelheim Pharma In vitro-Screening-Assay für gamma-Secretase
MXPA04012783A (es) * 2002-06-27 2005-02-24 Fujisawa Pharmaceutical Co Derivados de aminoalcohol.
GB0305918D0 (en) * 2003-03-14 2003-04-23 Glaxo Group Ltd Novel compounds
WO2005110963A1 (fr) * 2004-05-19 2005-11-24 Cellzome Ag Acides (biphenyl-3-yl)-carboxyliques et derives de ceux-ci ainsi que leur utilisation en therapie
GB0416508D0 (en) * 2004-07-23 2004-08-25 Merck Sharp & Dohme Therapeutic agents
JPWO2006022237A1 (ja) * 2004-08-24 2008-05-08 キッセイ薬品工業株式会社 脂肪肝の予防または治療剤
WO2007039736A1 (fr) 2005-10-06 2007-04-12 Astrazeneca Ab Nouveaux composes

Also Published As

Publication number Publication date
PE20080364A1 (es) 2008-05-16
SI1849762T1 (sl) 2009-12-31
MY148953A (en) 2013-06-14
EP2021314A1 (fr) 2009-02-11
NO20084517L (no) 2009-01-13
US7557244B2 (en) 2009-07-07
EP2021314B1 (fr) 2013-01-23
TW200815320A (en) 2008-04-01
TWI399362B (zh) 2013-06-21
MA30475B1 (fr) 2009-06-01
CR10451A (es) 2009-03-31
EA200802172A1 (ru) 2009-06-30
GT200900120A (es) 2009-11-16
EA016129B9 (ru) 2012-06-29
UY30301A1 (es) 2007-08-31
AU2007240335B2 (en) 2013-05-02
ES2400530T3 (es) 2013-04-10
KR101542255B1 (ko) 2015-08-06
UA95952C2 (ru) 2011-09-26
AR060568A1 (es) 2008-06-25
IL194852A0 (en) 2009-08-03
CA2650006C (fr) 2016-08-23
BRPI0710656A2 (pt) 2011-08-16
ZA200809856B (en) 2009-06-24
EP1849762B1 (fr) 2009-07-15
AU2007240335A1 (en) 2007-11-01
PT1849762E (pt) 2009-09-16
AP2008004656A0 (en) 2008-10-31
IL194790A0 (en) 2009-08-03
US20070293567A1 (en) 2007-12-20
CY1109399T1 (el) 2014-07-02
CA2650006A1 (fr) 2007-11-01
EA016129B1 (ru) 2012-02-28
EP1849762A1 (fr) 2007-10-31
SMP200800061B (it) 2009-07-14
KR20090024679A (ko) 2009-03-09
CN101687758B (zh) 2014-05-14
CN101687758A (zh) 2010-03-31
IL194790A (en) 2012-12-31
CR10375A (es) 2009-02-26
MX2008013445A (es) 2009-03-10
SMAP200800061A (it) 2008-11-19
JP2009544573A (ja) 2009-12-17
TNSN08413A1 (en) 2010-04-14
NZ573000A (en) 2011-11-25
DE602006007810D1 (de) 2009-08-27
GEP20115269B (en) 2011-08-25
JP5479088B2 (ja) 2014-04-23
ES2328616T3 (es) 2009-11-16
WO2007124394A1 (fr) 2007-11-01
PL1849762T3 (pl) 2009-12-31

Similar Documents

Publication Publication Date Title
DK2063907T3 (da) Fremgangsmåder og sammensætninger baseret på difteritoksin-interleukin-3-konjugater
DK3263589T5 (da) Peptidsekvenser og sammensætninger
DK2081955T3 (da) Metastinderivater og anvendelse deraf
DE602006008266D1 (de) Klemm- und Gelenkelement
DK2016080T3 (da) Dihydropyrazolopyrimidinon-derivater
DK2046826T3 (da) Exendin-fusionsproteiner
ATE469905T1 (de) Pyridopyrimidinonderivate
DK1969391T3 (da) Tyndfilm emitter-absorber indretning og fremgangsmåde
DK1805129T3 (da) (Biphenyl-)carboxylsyrer og derivater deraf
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf
DK2035394T3 (da) 2-pyrazincarboxamidderivater
DK2079485T3 (da) Phenylpropionamidforbindelser og anvendelsen deraf
DK2190991T3 (da) SDF-1-Bindende nucleinsyrer og anvendelsen deraf
NO20054709D0 (no) Sammenfoyningssystem og anvendelse av dette
DK2160336T3 (da) Forbindelsesmekanisme og fremgangsmåde
DK2114393T3 (da) Farmaceutiske sammensætninger omfattende trigonellin og 4-hydroxyisoleucin og fremgangsmåde hertil
ATE544764T1 (de) 5-hydroxymethyloxazolidin-2-onderivate
DK2158199T3 (da) Piperidinforbindelser og anvendelser deraf
DK1999403T3 (da) Multikoblingssystem og fremgangsmåde relateret dertil
DK2029561T3 (da) Tricyclisk forbindelse og farmaceutisk anvendelse deraf
NO20075424L (no) Fremgangsmate og anvendelse
DK1885716T3 (da) Thiazolderivater og anvendelse deraf
DK1863801T3 (da) Benzimidazolderivat og anvendelse deraf
DE602006007810D1 (de) Substituierte Biphenylcarbonsäuren und deren Derivate